Furthermore, crossing of an AD transgenic mouse with a PARP-1 (−/−) mouse was able to prevent cognitive dysfunction, synaptic damage and microglial activation (Kauppinen et al., 2011). Here, PARP1 is linked to Alzheimer disease.